Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Curious as to how the trial changes affect posted results !

<< Previous

Bullboard Posts

Next >>

Comment by Donein25on May 10, 2024 10:47am

161 Views

Post# 36033511

RE:Curious as to how the trial changes affect posted results !

I think there will have to be new data sets because there will be new subsets of patients. Also, I think (due to BTD/AA requirements) that we might start to see 2 year data soon. I personally would be encouraged to see 2 year data come out...as it would say to me that we are complying with current FDA reporting requirements.

<< Previous

Bullboard Posts

Next >>

5 steps to mastering risk management in the stock market